Source: Health Canada shortage reports · Updated Jul 16, 2026
Some Clopidogrel products are in shortage in Canada (4 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 10, 2026.
An antiplatelet medication used to prevent blood clots, heart attacks and strokes.
Products affected
4 / 18
In shortage since
Sep 17, 2018
Est. full return
Nov 10, 2026
Reports on file
108
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-CLOPIDOGREL
300MG · TABLET · APOTEX INC
DIN 02398591 · since Jun 9, 2026, est. end Aug 21, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-CLOPIDOGREL
75MG · TABLET · TEVA CANADA LIMITED
DIN 02293161 · since Jun 24, 2026, est. end Nov 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-CLOPIDOGREL
300MG · TABLET · TEVA CANADA LIMITED
DIN 02388065 · since Nov 25, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-CLOPIDOGREL
300MG · TABLET · APOTEX INC
DIN 02398591 · since Oct 8, 2025, est. end Apr 17, 2026 · Disruption of the manufacture of the drug.
Active shortage
MAR-CLOPIDOGREL
75MG · TABLET · MARCAN PHARMACEUTICALS INC
DIN 02422255 · since Sep 17, 2018, no end estimate · Business reasons
Resolved
M-CLOPIDOGREL
75MG · TABLET · MANTRA PHARMA INC
DIN 02502283 · ended Feb 10, 2026 · Delay in shipping of the drug.
Resolved
CLOPIDOGREL
75MG · TABLET · SANIS HEALTH INC
DIN 02400553 · ended Feb 2, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Jan 15, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Feb 19, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Feb 19, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Dec 4, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-CLOPIDOGREL
75MG · TABLET · APOTEX INC
DIN 02252767 · ended Dec 4, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Clopidogrel is currently affected by 4 active shortage reports filed with Health Canada by APOTEX INC, TEVA CANADA LIMITED, MARCAN PHARMACEUTICALS INC.
The reported causes are: disruption of the manufacture of the drug; business reasons. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Clopidogrel is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AC).
Recent changes
Jul 16, 2026
Estimated end date moved earlier : Sep 4, 2026 → Aug 21, 2026
Jul 9, 2026
Estimated end date pushed back : Aug 14, 2026 → Sep 4, 2026
Common questions
What is Clopidogrel used for?
An antiplatelet medication used to prevent blood clots, heart attacks and strokes.
When will Clopidogrel be back in stock in Canada?
The latest manufacturer estimate is Nov 10, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Clopidogrel in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.